Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
MACFIE, CRAIGIE
1980.
PSYCHIATRY.
Medical Journal of Australia,
Vol. 1,
Issue. 9,
p.
405.
Remy, David C.
and
Martin, Gregory E.
1980.
Vol. 15,
Issue. ,
p.
12.
Pietzcker, A.
Poppenberg, A.
Schley, J.
and
Müller-Oerlinghausen, B.
1981.
Outcome and risks of ultra-long-term treatment with an oral neuroleptic drug.
Archiv für Psychiatrie und Nervenkrankheiten,
Vol. 229,
Issue. 4,
p.
315.
Linden, Robert
Davis, John M.
and
Rubinstein, Joan
1984.
Guidelines for the Use of Psychotropic Drugs.
p.
151.
Pietzcker, A.
1984.
Prävention in der Psychiatrie.
p.
104.
Retterstøl, N.
1987.
Schizophrenien.
Vol. 4,
Issue. ,
p.
71.
Lambert, Tim J.
Singh, Bruce S.
and
Patel, Maxine X.
2009.
Community treatment orders and antipsychotic long-acting injections.
British Journal of Psychiatry,
Vol. 195,
Issue. S52,
p.
s57.
Patel, Maxine X.
Taylor, Mark
and
David, Anthony S.
2009.
Antipsychotic long-acting injections: Mind the gap.
British Journal of Psychiatry,
Vol. 195,
Issue. S52,
p.
s1.
Agid, Ofer
Foussias, George
and
Remington, Gary
2010.
Long-acting injectable antipsychotics in the treatment of schizophrenia: their role in relapse prevention.
Expert Opinion on Pharmacotherapy,
Vol. 11,
Issue. 14,
p.
2301.
Citrome, Leslie
Jaffe, Ari
and
Levine, Jerome
2010.
Treatment of schizophrenia with depot preparations of fluphenazine, haloperidol, and risperidone among inpatients at state-operated psychiatric facilities.
Schizophrenia Research,
Vol. 119,
Issue. 1-3,
p.
153.
Olivares, José M
Pinal, Beatriz
and
Cinos, Carmen
2011.
Comparison of long-acting antipsychotic injection and oral antipsychotics in schizophrenia.
Neuropsychiatry,
Vol. 1,
Issue. 3,
p.
275.